李氏大药厂控股有限公司于2026年3月2日披露的截至2026年2月28日止股份变动月报表显示，法定/注册股本维持在1,000,000,000股，每股面值0.05港元，合共50,000,000港元。该公司本月末已发行股份数量为588,835,343股，与上月末持平，未有新增发行或回购注销活动，库存股份数量为零。
报告期内，公司在2012年5月10日及2022年5月19日通过并采纳的购股权计划仍分别保持21,679,000份和4,778,000份期权，无新增授予或行使记录。李氏大药厂控股有限公司确认，截至本月末其公众持股量符合相关监管要求，且所有股份变动事项均严格遵守香港联交所《上市规则》等法律法规。根据公告信息，本月报表由公司董事李小芳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.